Non-equipotent doses partly explain differences among antipsychotics - implications of PET studies.
Nyberg
S
S
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, 171 76 Stockholm, Sweden.
Farde
L
L
D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D017448:Receptors, Dopamine D2 / Q000187:drug effects / Q000378:metabolism; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D017448:Receptors, Dopamine D2